News

Nike's Earnings Forecast: What Investors Should Expect

Nike's Earnings Forecast: What Investors Should Expect

Nike's Earnings Forecast: What to Expect

Nike (NYSE:NKE) is on the brink of releasing its quarterly earnings report, slated for December 18, 2025. This announcement is generating considerable interest among investors eager to glean insights on the company's financial performance and future direction.

Projected Earnings Per Share

Analysts are anticipating that Nike will report an earnings per share (EPS) of $0.37. However, the excitement doesn't just stem from this figure; investors are also looking for indications that the company might surpass this expectation.

Market Reactions to Previous Earnings

Understanding Past Performance

In the prior quarter, Nike's EPS exceeded expectations by $0.22, resulting in a notable 6.41% increase in its share price the following day. Such performance highlights the potential volatility that earnings reports can introduce into stock prices.

Historical Earnings Performance Exploration

Reflecting on Nike's historical performance, here's an overview:

Current Stock Performance Insights

As of mid-December, shares of Nike were trading at $67.12, marking a 12.94% decline over the past year. This trend could leave some long-term investors feeling uneasy as the company prepares for its earnings release.

Analyst Predictions and Market Sentiment

Consensus Rating Breakdown

Staying informed about the sentiments and expectations surrounding Nike is crucial for investors. Currently, Nike holds a consensus rating of Neutral from 20 analysts, with an average one-year price target of $79.50, suggesting a potential upside of 18.44% from current levels.

Peer Comparison of Analysts' Ratings

When comparing Nike with its competitors in the athletic wear market, it's essential to evaluate their performance as well. The ratings and price targets for significant industry players include:

  • On Holding is seen as an Outperform, with an average price target forecast of $61.65, suggesting an 8.15% downside.
  • Deckers Outdoor is favored with a Buy rating, projecting a strong potential upside of 68.92% with a price target set at $113.38.
  • Birkenstock Holding is similarly rated as Outperform, with a minor upside potential of 0.72% expected with a price target set at $67.60.

Analyzing Financial Metrics

Key Takeaways from Recent Market Analysis

During a recent peer analysis, various metrics have been collected for Nike and its competitors, revealing useful insights into their positions within the industry:

CompanyConsensusRevenue GrowthGross ProfitReturn on Equity
NikeNeutral1.13%$4.94B5.45%
On HoldingOutperform24.95%$522.20M8.09%
Deckers OutdoorBuy9.11%$803.82M10.87%
Birkenstock HoldingOutperform12.45%$384.08M4.76%

Nike currently holds a neutral consensus among its peers but ranks lower in revenue growth and profitability metrics, indicating room for improvement.

Understanding Nike's Business Framework

As the world's leading athletic footwear and apparel brand, Nike boasts a broad portfolio, with footwear comprising about two-thirds of its total sales. Key categories include basketball, running, and football (soccer). The company operates globally through various channels, including company-owned, franchised, and e-commerce platforms across over 40 countries. Despite being a market leader, Nike outsources a majority of its production to more than 30 countries.

Nike's Financial Health Assessment

Detailed Financial Overview

Focusing on key financial metrics:

Market Capitalization: Nike's substantial market capitalization positions it favorably within the industry, showcasing its notable market presence.

Revenue Growth: Recent financial performance reveals a revenue growth rate of 1.13% as of late August 2025, slightly trailing its competitors in the Consumer Discretionary sector.

Profitability Metrics: Nike's net margin is impressive at 6.2%, emphasizing effective cost management and profitability. In addition, its ROE stands at 5.45%, showcasing a robust utilization of equity.

Debt Analysis: Nike's debt-to-equity ratio of 0.82 suggests a relatively high leverage, prompting a need for careful financial management moving forward.

Frequently Asked Questions

What is Nike's anticipated EPS for the upcoming earnings report?

Nike is expected to report an earnings per share (EPS) of $0.37 for the quarter.

How did Nike's stock perform after its last earnings release?

Following the last quarter's earnings release, Nike's stock rose by 6.41% due to an EPS beat of $0.22.

What is the current stock price of Nike?

The last recorded stock price of Nike was $67.12 as of December 16.

How does Nike's performance compare to its peers?

Nike has a neutral consensus rating among analysts but lags in revenue growth compared to competitors like Deckers Outdoor and On Holding.

What are analysts' ratings for Nike?

Analysts generally rate Nike with a consensus rating of Neutral, with an average price target of $79.50, signaling potential upside.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

China-Kyrgyzstan Ties Strengthen Amid Landmark Projects

Updated Category News Views 3

You've gotta tip your hat to strategic partnerships, especially when you have China and Kyrgyzstan starting what they're dubbing a 'golden' era of friendship. In true form, Chinese President Xi Jinping's visit to Bishkek lays down marker after marker showing just how cozy these two are becoming. The Belt and Road Push Let's not beat around the bush—a big part of this...

Continue Reading
Decoding Insurance Choices: Tulsa Drivers' Dilemma

Updated Category News Views 8

Insurance Jargon: Navigating the Tulsa Terrain Insurance. If you’ve ever tried to wrap your head around this beast, you know it’s not the friendliest thing on the block. For the folks in Tulsa, Oklahoma, understanding the difference between full coverage and liability insurance isn’t just an idle exercise—it's critical. There's more at stake than just a piece of...

Continue Reading
Kazia's Oversubscribed Offering: Big Bucks Ahead?

Updated Category News Views 0

High-Stakes Play for Kazia: What the Oversubscription Means When a biotech like Kazia Therapeutics Limited (NASDAQ: KZIA) sits at the table with a $120 million public offering, you don't just glance at the cards—they're all in, chips on the line. Bursting with promise, they’re pushing the frontier of oncology therapeutics, with a cash bonanza expected if everything...

Continue Reading
Daraxonrasib: New Lifeline for Metastatic Pancreatic Cancer

Updated Category News Views 6

New Hope on the Horizon Some medical breakthroughs feel like rays of sunshine breaking through dense clouds, and this one is no different. Karmanos Cancer Institute, a pillar of cancer research for over seven decades, has added a new weapon to its arsenal with the introduction of daraxonrasib (Rasonque) for metastatic pancreatic cancer patients. Approved by the FDA on...

Continue Reading
Sealaska: Building Prosperity with Traditional Values

Updated Category News Views 0

Traditional Values Meet Modern Enterprise The world does a double-take whenever Indigenous values meet business might, but here comes Sealaska proving they’re more than capable at uniting both fronts. Founded under the Alaska Native Claims Settlement Act (ANCSA) in 1971, this behemoth of Southeast Alaska is synchronizing age-old wisdom with cutting-edge business acumen,...

Continue Reading
Forbes Honors BAILOR CEO for Transformative Insight

Updated Category News Views 9

The market's buzzing with chatter about Sonya Bailor, CEO of BAILOR, landing a coveted Editor's Choice nod from Forbes for her insightful take on business scalability. Now, you might be wondering what sets her apart from the plethora of business gurus spouting strategies. Well, it isn't just another recycled spiel—it dives deep into what she calls the 'missing variable'...

Continue Reading
Yale Secures $25M for Autism and Brain Research Breakthroughs

Updated Category News Views 5

Pioneering Autism Research Imagine embarking on a scientific journey to navigate the complex pathways of the human brain. Yale School of Medicine is doing precisely that with a hefty $25 million grant from the Aligning Research to Impact Autism (ARIA) initiative. This substantial chunk of change is about to launch a high-flying investigation into brain development, aiming...

Continue Reading
Microsoft & HUMAIN Drive New AI Frontier in MEA

Updated Category News Views 5

Pioneering AI Innovations at LEAP 2026 Microsoft and HUMAIN aren't just playing around—they're in it to redefine the rules of AI-driven workplace innovation. At LEAP 2026, these two have announced a robust expansion to their strategic collaboration, bringing to the table enterprise AI applications and devices that promise to shake things up across the Middle East and...

Continue Reading
Texas Unveils New Hotels and Adventures in 2026

Updated Category News Views 6

Texan Travel: A New Era of Experiences When you're talking Texas, you're talking big ideas and bigger landscapes. Now, they're adding even more reasons for folks to lace up their boots and head down south. Expanding faster than humidity on a summer day, Texas tourism is set to reach new heights with a slew of new hotels, attractions, and culinary excitement. Hotels:...

Continue Reading
BOLT ON's Employee-Driven Culture Steers Recognition

Updated Category News Views 7

Employee Applause Drives BOLT ON's Success When your team claps for you, that's when you know you're doing things right. BOLT ON Technology hit the big times as a 2026 Top Workplace, with eight more accolades from Energage to make any CEO blush. How did they do it? By listening to the real MVPs: their employees. Award Celebrations Based on Genuine Feedback Some awards...

Continue Reading

Top 5 Most Recently Viewed Articles

Normatec Elite by Hyperice Earns Spot on TIME's 2024 Innovations

Updated Category News Views 390

Normatec Elite Recognized by TIME for Innovation In a remarkable achievement, Hyperice's Normatec Elite has been honored in TIME's yearly list of the Best Inventions for 2024. This prestigious recognition showcases innovative technologies that are making significant impacts in our daily lives. Normatec Elite represents the latest advancement in dynamic air compression...

Continue Reading
Carter's Earnings Anticipation: What Investors Should Know

Updated Category News Views 103

Understanding Carter's Upcoming Earnings Release Carter's (NYSE: CRI) is gearing up to announce its quarterly earnings soon. With significant interest from investors, this preview outlines crucial insights to consider leading up to the release. Expectations are set high, with analysts projecting an earnings per share (EPS) figure of approximately $1.34. Investors are...

Continue Reading
Infineon Achieves Major Legal Win Against Innoscience in Patent Case

Updated Category News Views 197

Infineon's Patent Victory: Implications for the Industry The U.S. International Trade Commission (ITC) has made a significant ruling in favor of Infineon Technologies AG regarding a patent infringement case against Innoscience. This decision could potentially lead to an import ban on Innoscience's products within the United States. Such a ban highlights the importance of...

Continue Reading
Prime Drink Group Completes Acquisition of Triani Canada Inc.

Updated Category News Views 217

Prime Drink Group Completes Acquisition of Triani Canada Inc. Prime Drink Group Corp. (CSE: PRME) has successfully closed its acquisition of Triani Canada Inc., marking a significant step in expanding its beverage portfolio. By acquiring all issued and outstanding shares of Triani Canada, Prime Drink Group is poised to enhance its operational capabilities and product...

Continue Reading
Meet One Trike Unveils Breeze Pro and Tour Lite Innovations

Updated Category News Views 537

Meet One Trike Expands Its Electric Tricycle Lineup Meet One Trike proudly announces the launch of its enhanced electric tricycle models, the Breeze Pro and Tour Lite. These innovative additions are designed to provide improved accessibility and performance, making cycling enjoyable for everyone, no matter their ability or experience level. Introducing the Breeze Pro The...

Continue Reading